Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
QCOR [NASD]
Questcor Pharmaceuticals, Inc.
Index- P/E16.52 EPS (ttm)4.73 Insider Own1.00% Shs Outstand60.58M Perf Week0.08%
Market Cap4.73B Forward P/E10.06 EPS next Y7.77 Insider Trans-66.45% Shs Float59.36M Perf Month25.91%
Income292.60M PEG0.56 EPS next Q1.61 Inst Own- Short Float30.23% Perf Quarter25.65%
Sales798.90M P/S5.93 EPS this Y51.60% Inst Trans0.38% Short Ratio5.91 Perf Half Y19.87%
Book/sh6.72 P/B11.63 EPS next Y10.29% ROA50.60% Target Price87.43 Perf Year179.17%
Cash/sh4.04 P/C19.32 EPS next 5Y29.47% ROE94.20% 52W Range27.73 - 85.36 Perf YTD44.84%
Dividend1.20 P/FCF16.55 EPS past 5Y57.60% ROI70.60% 52W High-8.49% Beta0.90
Dividend %1.54% Quick Ratio2.40 Sales past 5Y53.00% Gross Margin90.70% 52W Low181.64% ATR3.62
Employees703 Current Ratio2.50 Sales Q/Q51.30% Oper. Margin55.30% RSI (14)56.09 Volatility2.75% 5.07%
OptionableYes Debt/Eq0.04 EPS Q/Q39.80% Profit Margin36.60% Rel Volume0.86 Prev Close78.14
ShortableYes LT Debt/Eq0.04 EarningsApr 28 Payout20.20% Avg Volume3.04M Price78.11
Recom2.30 SMA206.72% SMA5012.10% SMA20026.60% Volume703,443 Change-0.04%
21-Apr-14Reiterated Oppenheimer Outperform $99 → $86
26-Feb-14Reiterated Oppenheimer Outperform $90 → $99
26-Feb-14Reiterated Ladenburg Thalmann Buy $84 → $85
26-Feb-14Reiterated CRT Capital Fair Value $61 → $72
30-Oct-13Reiterated Mizuho Buy $84 → $93
30-Oct-13Downgrade CRT Capital Buy → Fair Value
19-Aug-13Reiterated Oppenheimer Outperform $57 → $73
12-Aug-13Reiterated Mizuho Buy $65 → $84
31-Jul-13Reiterated Oppenheimer Outperform $57 → $73
31-Jul-13Reiterated Mizuho Buy $62 → $65
31-Jul-13Reiterated Ladenburg Thalmann Buy $54 → $66
30-Jul-13Reiterated Mizuho Buy $50 → $62
21-Jun-13Resumed Oppenheimer Outperform $57
11-Jun-13Upgrade CRT Capital Hold → Buy $52
15-May-13Reiterated Mizuho Buy $41 → $50
01-May-13Reiterated Ladenburg Thalmann Buy $38 → $35
27-Feb-13Reiterated Ladenburg Thalmann Buy $33 → $38
21-Feb-13Upgrade Mizuho Neutral → Buy $28 → $41
30-Nov-12Initiated Mizuho Neutral $28
24-Oct-12Upgrade Ladenburg Thalmann Neutral → Buy $33
23-Apr-14 01:54AM  Valeant Pharmaceuticals International (VRX) Soars: Stock Up 7.5% Zacks
22-Apr-14 04:40PM  Eli Lilly to Acquire Novartis' Animal Health Biz Zacks
21-Apr-14 09:00AM  Clinical Trial Results Indicate Acthar May Significantly Reduce Proteinuria in Patients with Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy PR Newswire
17-Apr-14 09:00AM  Questcor Partners with National Kidney Foundation as National Sponsor of Kidney Walk PR Newswire
15-Apr-14 06:40AM  Flamel Technologies (FLML) in Focus: Stock Slumps 13.5% Zacks
14-Apr-14 07:45PM  QUESTCOR SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Questcor Pharmaceuticals Inc. Over the Proposed Sale of the Company to Mallinckrodt plc PR Newswire
10:30AM  3 Humongous Health-Care Stocks This Week at Motley Fool
11-Apr-14 02:21PM  INVESTOR ALERT Questcor Pharmaceuticals, Inc.: The Law Offices of Vincent Wong Investigates the Sale of Questcor Pharmaceuticals, Inc. to Mallinckrodt Business Wire
12:30PM  Lifshitz & Miller Law Firm Announces Investigation of Imperva, Inc., OBA Financial Services, Inc., Och-Ziff Capital Management Group LLC, Questcor Pharmaceuticals, Inc., Vocus, Inc. and Zygo Corporation PR Newswire
12:02PM  [video] Dr. J likes Twitter at CNBC
08:41AM  Questcor Pharmaceuticals (QCOR) Shares March Higher, Can It Continue? Zacks
10-Apr-14 08:02AM  PolyOne, Anika, Methode Among The Leading Small Caps at Investor's Business Daily
09-Apr-14 06:15PM  SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Questcor Pharmaceuticals, Inc. In Connection With the Sale of The Company Business Wire +5.46%
12:26PM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Questcor Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Mallinckrodt -- QCOR PR Newswire
11:32AM  A Response To Mallinckrodt And Questcor Investor Questions at Seeking Alpha
08-Apr-14 06:31PM  Questcor Buyout Shocks Short Sellers at Motley Fool
05:20PM  QUESTCOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Business Wire
04:15PM  Mallinckrodt to Acquire Questcor Zacks
03:35PM  Roche Acquires IQuum Zacks
02:10PM  SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Questcor Pharmaceuticals, Inc. - QCOR PR Newswire
12:39PM  Mallinckrodt Transfers Questcor's Risk Onto Its Shareholders at Seeking Alpha
12:18PM  INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of Questcor Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Mallinckrodt Business Wire
12:09PM  [$$] Questcor's Remarkable Rise Ends With Buyout at Barrons.com
11:19AM  Jim Cramer: In the Abstract, the Shorts May Be Right at TheStreet
10:42AM  Jim Cramer's Mad Dash: QCOR MNK at TheStreet
09:55AM  Drug Deals Surge to New High With Mallinckrodt: Real M&A at Bloomberg
09:32AM  Mallinckrodt plc Takes a Big Swing for Growth at Motley Fool
09:19AM  Company News for April 08, 2014 Zacks
08:02AM  Myriad, Tata Motors Among RS Leaders In Correction at Investor's Business Daily
06:46AM  In the Abstract, the Shorts May Be Right TheStreet
06:40AM  Mallinckrodt upgraded to Outperform from Market Perform at BMO Capital at theflyonthewall.com
02:35AM  Questcor Pharmaceuticals (QCOR) Shows Strength: Stock Surges 18.7% in Session Zacks
12:24AM  [$$] Mallinckrodt to Buy Questcor Pharmaceuticals for $5.6 Billion at The Wall Street Journal
07-Apr-14 10:44PM  [$$] Mallinckrodt to Buy Questcor Pharmaceuticals for $5.6 Billion at The Wall Street Journal +18.73%
08:52PM  [$$] Mallinckrodt to Buy Questcor Pharmaceuticals for $5.6 Billion at The Wall Street Journal
08:30PM  Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc. PR Newswire
08:15PM  QUESTCOR INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Questcor Pharmaceuticals Inc. (QCOR) Over the Proposed Sale of the Company to Mallinckrodt plc (MNK) Business Wire
07:54PM  Acquisition of Questcor Pharmaceuticals, Inc. by Mallinckrodt plc May Not Be in Shareholders' Best Interests PR Newswire
07:21PM  2014's Most Shocking Takeover at Motley Fool
06:32PM  Is There a Lesson to Be Learned in Mallinckrodt's Questcor Deal? at Motley Fool
06:32PM  QUESTCOR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Questcor Pharmaceuticals, Inc. PR Newswire
06:05PM  Mallinckrodt, Questcor Merger Gets Mixed Reception at Investor's Business Daily
06:02PM  Nasdaq stocks posting largest percentage increases AP
05:26PM  INVESTOR ALERT - Questcor Pharmaceuticals, Inc.: The Law Offices of Vincent Wong Investigates the Sale of Questcor Pharmaceuticals, Inc. to Mallinckrodt -- QCOR PR Newswire
04:28PM  On The Fly: Closing Wrap at theflyonthewall.com
04:24PM  Major Stock Indexes Close With Losses Of 1% Or More at Investor's Business Daily
04:20PM  SHAREHOLDER ALERT: Brower Piven Announces the Investigation of Questcor Pharmaceuticals Inc. over the Proposed Sale of the Company to Mallinckrodt plc Business Wire
03:54PM  Tesla, Facebook seesaw; Questcor surges on deal at MarketWatch
03:30PM  SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Questcor Pharmaceuticals, Inc. - QCOR PR Newswire
03:03PM  Mallinckrodt buying Questcor for about $5.6B at USA TODAY
02:46PM  Mallinckrodt to buy Questcor for lucrative MS drug Reuters
02:37PM  Pfizer's Plunge Leads the Dow's Triple-Digit Dive at Motley Fool
02:34PM  [video] Lot of uncertainty surrounding Questcor: Greenberg at CNBC
02:05PM  2 Big Stocks the Crowd Is Talking About at TheStreet
01:50PM  Nasdaq stocks posting largest percentage increases AP
01:15PM  [video] Mallinckrodt Gets Money-Making Acthar Gel by Acquiring Questcor at TheStreet
12:57PM  Why Questcor Pharmaceuticals Inc. Shares Skyrocketed at Motley Fool
12:56PM  Questcor Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Mallinckrodt plc PR Newswire
12:42PM  Questcor Pharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Mallinckrodt Business Wire
12:35PM  Independent again after 31 years, Mallinckrodt now in acquisition game at MarketWatch
12:15PM  On The Fly: Midday Wrap at theflyonthewall.com
12:07PM  Mallinckrodt to Buy Questcor: 5 Deals That Blew Up the Short-Sellers at TheStreet
12:01PM  Major Averages Face More Selling, Biotechs Rally Back at Investor's Business Daily
12:00PM  QUESTCOR INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Questcor Pharmaceuticals Inc. (QCOR) Over the Proposed Sale of the Company to Mallinckrodt plc (MNK) Business Wire
11:57AM  Mallinckrodt Acquires Questcor for $5.6B at TheStreet
11:47AM  Mallinckrodt buying Questcor for about $5.6B AP
11:47AM  Yelp leaping; Sears spins off Lands End; Questcor boosting biotech Breakout
11:31AM  Tesla, Facebook seesaw; Questcor surges on buyout at MarketWatch
11:17AM  INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of Questcor Pharmaceuticals, Inc. and Its Board of Directors in Connection with the Sale of the Company to Mallinckrodt Business Wire
11:15AM  Why Questcor Buyout Will Not Deter Short Sellers 24/7 Wall St.
11:07AM  [$$] Mallinckrodt to Buy Questcor Pharmaceuticals for $5.6 Billion at The Wall Street Journal
10:59AM  QUESTCOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Business Wire
10:58AM  Mallinckrodt buying Questcor for about $5.6B AP
10:44AM  Mallinckrodt to buy Questcor for its lucrative MS drug Reuters
10:40AM  Short-seller target Questcor spikes after deal to be bought by Mallinckrodt at theflyonthewall.com
09:59AM  [video] Mon., April 7: Eyes on Alcoa's Earnings Report at MarketWatch
09:49AM  Mallinckrodt buying Questcor for about $5.2 billion at Los Angeles Times
09:43AM  Greenberg: Questcor Smart Seller, Mallinckrodt Dumb Buyer? at TheStreet
09:41AM  $5.6 Billion Questcor Deal Means High Drug Prices For Everybody at Forbes
09:19AM  Todays Top Biotech Stories: MannKind, Mallinckrodt, Questcor, and Novartis at Motley Fool
09:18AM  Morning Movers: Tesla Falls on California Credit Reduction; Nasdaq Slap Down Continues at Barrons.com
09:17AM  QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or P EDGAR Online
09:10AM  On The Fly: Pre-market Movers at theflyonthewall.com
09:08AM  Mallinckrodt to buy Questcor for its lucrative MS drug Reuters
09:06AM  [$$] Mallinckrodt to Buy Questcor Pharmaceuticals for $5.6 Billion at The Wall Street Journal
09:06AM  Stock Futures Lean Lower; Mallinckrodt Acquires Questcor at Investor's Business Daily
09:05AM  [video] Mallinckrodt to acquire Questcor at CNBC
09:04AM  Mallinckrodt buying Questcor for about $5.2B AP
09:01AM  Stock Market Today: A Record Weekend for Captain America and Yahoo!s Big TV Plans at Motley Fool
08:48AM  [$$] Mallinckrodt to Buy Questcor Pharmaceuticals for $5.6 Billion at The Wall Street Journal
08:13AM  Mallinckrodt to buy Questcor in cash-and-shares deal at MarketWatch
08:06AM  [$$] Mallinckrodt to Buy Questcor Pharmaceuticals for $5.6 Billion at The Wall Street Journal
07:48AM  Early movers: QCOR, SYMC, GM, UA, PFE, EGN & more at CNBC
07:43AM  Mallinckrodt to buy Questcor in cash-and-shares deal at MarketWatch
07:42AM  [$$] Mallinckrodt to Buy Questcor Pharmaceuticals at The Wall Street Journal
07:41AM  Mallinckrodt buying Questcor for about $5.2B AP
07:15AM  Mallinckrodt to Buy Questcor for $5.6 Billion at Bloomberg
07:15AM  Questcor Announces Quarterly Cash Dividend PR Newswire
07:11AM  Mallinckrodt to buy Questcor Pharma for about $5.6 bln Reuters
07:08AM  Questcor to be bought by Mallinckrodt for cash, stock valued at $86.10 per share theflyonthewall.com
Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides drugs for the treatment of autoimmune and inflammatory disorders. The company primarily offers H.P. Acthar Gel, an injectable drug to induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus; as exacerbation or maintenance therapy in various cases of systemic lupus erythematosus and systemic dermatomyositis; and as adjunctive therapy for short-term administration in psoriatic arthritis, rheumatoid arthritis, and ankylosing spondylitis. Its H.P. Acthar Gel is also used for the treatment of acute exacerbations of multiple sclerosis in adults; and as monotherapy for the treatment of infantile spasms in infants and children under two years of age. The company sells its product primarily to specialty pharmacies. Questcor Pharmaceuticals, Inc. was founded in 1990 and is headquartered in Anaheim, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAILEY DON MPresident and CEOApr 14Option Exercise5.1240,000204,800139,000Apr 15 08:45 PM
BAILEY DON MPresident and CEOApr 14Sale79.6540,0003,186,18999,000Apr 15 08:45 PM
Mulroy Michael H.See RemarksApr 10Option Exercise14.2410,000142,40087,063Apr 14 07:09 PM
Mulroy Michael H.See RemarksApr 10Sale85.0410,000850,40077,063Apr 14 07:09 PM
SILVERMAN LOUDirectorApr 07Option Exercise4.0810,00040,80024,183Apr 09 08:08 PM
SILVERMAN LOUDirectorApr 07Sale84.5710,000845,70014,183Apr 09 08:08 PM
FARRELL STEPHEN CDirectorApr 07Sale84.577,500634,27520,433Apr 07 07:24 PM
BROADWOOD PARTNERS LPDirectorApr 07Sale83.96205,00017,212,0872,046,660Apr 09 05:45 PM
FARRELL STEPHEN CDirectorApr 03Sale72.002,500180,00020,433Apr 07 07:24 PM
Young DavidChief Scientific OfficerMar 14Option Exercise4.546,00027,240117,741Mar 18 04:05 PM
Young DavidChief Scientific OfficerMar 14Sale62.286,000373,669111,741Mar 18 04:05 PM
BAILEY DON MPresident and CEOMar 13Option Exercise5.1240,000204,800139,000Mar 17 04:05 PM
BAILEY DON MPresident and CEOMar 13Sale62.7140,0002,508,29299,000Mar 17 04:05 PM
Mulroy Michael H.See RemarksMar 10Option Exercise14.2410,000142,40087,063Mar 12 06:16 PM
Mulroy Michael H.See RemarksMar 10Sale64.8010,000647,99177,063Mar 12 06:16 PM
FARRELL STEPHEN CDirectorMar 07Sale65.215,000326,06415,433Mar 11 08:01 PM
Medeiros David JeffreyEVP and CTOMar 03Option Exercise35.7883429,841120,873Mar 05 07:47 PM
Young DavidChief Scientific OfficerMar 03Option Exercise5.776,00034,620111,741Mar 05 07:43 PM
Medeiros David JeffreyEVP and CTOMar 03Sale62.0083451,708120,039Mar 05 07:47 PM
BROADWOOD PARTNERS LPDirectorFeb 25Sale80.0812,6001,008,9462,251,660Feb 26 06:02 PM
Young DavidChief Scientific OfficerFeb 24Option Exercise4.546,00027,240111,351Feb 26 08:03 PM
BROADWOOD PARTNERS LPDirectorFeb 24Sale79.5071,0005,644,8412,264,260Feb 26 06:02 PM
Young DavidChief Scientific OfficerFeb 24Sale78.886,000473,290105,351Feb 26 08:03 PM
BROADWOOD PARTNERS LPDirectorFeb 20Sale77.7391,4007,104,8512,335,260Feb 20 06:06 PM
Medeiros David JeffreyEVP and CTOFeb 19Option Exercise25.992,29259,563120,343Feb 21 06:39 PM
BROADWOOD PARTNERS LPDirectorFeb 19Sale76.026,500494,1612,426,660Feb 20 06:06 PM
Medeiros David JeffreyEVP and CTOFeb 19Sale75.022,292171,935118,051Feb 21 06:39 PM
BROADWOOD PARTNERS LPDirectorFeb 18Sale73.68208,50015,361,9262,433,160Feb 20 06:06 PM
BAILEY DON MPresident and CEOFeb 13Option Exercise5.1140,000204,400139,000Feb 18 07:44 PM
BAILEY DON MPresident and CEOFeb 13Sale69.5640,0002,782,30599,000Feb 18 07:44 PM
BROADWOOD PARTNERS LPDirectorFeb 12Sale69.8337,0002,583,7472,641,660Feb 13 05:32 PM
BROADWOOD PARTNERS LPDirectorFeb 11Sale68.5448,0003,289,8862,678,660Feb 13 05:32 PM
BROADWOOD PARTNERS LPDirectorJan 30Sale67.0125,0001,675,3502,726,660Jan 31 05:52 PM
Young DavidChief Scientific OfficerJan 29Option Exercise7.5420,000150,800111,145Jan 31 08:19 PM
BROADWOOD PARTNERS LPDirectorJan 29Sale66.1025,0001,652,3752,751,660Jan 31 05:52 PM
Medeiros David JeffreyEVP and CTOJan 27Option Exercise35.7883329,805118,884Jan 29 08:07 PM
Medeiros David JeffreyEVP and CTOJan 27Sale63.7383353,087118,051Jan 29 08:07 PM
Young DavidChief Scientific OfficerJan 24Option Exercise4.546,00027,24097,145Jan 28 07:46 PM
Young DavidChief Scientific OfficerJan 24Sale64.386,000386,29491,145Jan 28 07:46 PM
Medeiros David JeffreyEVP and CTOJan 23Option Exercise18.47129,4782,391,161166,280Jan 23 08:26 PM
BROADWOOD PARTNERS LPDirectorJan 23Sale65.0020,0001,300,0002,776,660Jan 27 06:35 PM
Medeiros David JeffreyEVP and CTOJan 23Sale65.00129,4788,416,070118,051Jan 23 08:26 PM
Medeiros David JeffreyEVP and CTOJan 21Option Exercise16.894,06368,631119,822Jan 23 08:26 PM
Medeiros David JeffreyEVP and CTOJan 21Sale62.004,063251,906118,051Jan 23 08:26 PM
Medeiros David JeffreyEVP and CTOJan 16Option Exercise5.1150,000255,700153,051Jan 21 08:21 PM
Medeiros David JeffreyEVP and CTOJan 16Sale62.0050,0003,100,000118,051Jan 21 08:21 PM
BAILEY DON MPresident and CEOJan 13Option Exercise5.1040,000204,000139,000Jan 15 08:30 PM
BAILEY DON MPresident and CEOJan 13Sale53.6440,0002,145,59399,000Jan 15 08:30 PM
BAILEY DON MPresident and CEODec 13Option Exercise5.1040,000204,000139,000Dec 17 05:54 PM
BAILEY DON MPresident and CEODec 13Sale53.3040,0002,132,16899,000Dec 17 05:54 PM
Young DavidChief Scientific OfficerNov 19Option Exercise5.7715,00086,55089,603Nov 21 05:20 PM
BRADSHER NEAL CDirectorNov 14Option Exercise0.8640,00034,25044,183Nov 15 07:28 PM
BRADSHER NEAL CDirectorNov 14Sale62.4140,0002,496,2374,183Nov 15 07:28 PM
BAILEY DON MPresident and CEONov 13Option Exercise5.1040,000204,000139,000Nov 15 07:06 PM
Young DavidChief Scientific OfficerNov 13Option Exercise4.54100,000454,000174,603Nov 15 07:10 PM
Young DavidChief Scientific OfficerNov 13Sale62.40100,0006,240,03074,603Nov 15 07:10 PM
BAILEY DON MPresident and CEONov 13Sale62.4440,0002,497,52399,000Nov 15 07:06 PM
BROADWOOD PARTNERS LPDirectorNov 13Sale62.56174,03410,886,8012,796,660Nov 13 07:15 PM
BROADWOOD PARTNERS LPDirectorNov 12Sale62.28195,84412,197,2432,970,694Nov 13 07:15 PM
BROADWOOD PARTNERS LPDirectorNov 11Sale62.25130,1228,099,7953,166,538Nov 13 07:15 PM
BAILEY DON MPresident and CEOOct 14Option Exercise5.1040,000204,000139,000Oct 16 06:51 PM
THOMPSON VIRGIL DDirectorOct 14Option Exercise4.502,50011,25032,367Oct 16 06:57 PM
THOMPSON VIRGIL DDirectorOct 14Sale60.502,500151,25429,867Oct 16 06:57 PM
BAILEY DON MPresident and CEOOct 14Sale62.1640,0002,486,53299,000Oct 16 06:51 PM
THOMPSON VIRGIL DDirectorSep 16Option Exercise4.505,00022,50034,867Sep 18 07:02 PM
THOMPSON VIRGIL DDirectorSep 16Sale63.755,000318,73629,867Sep 18 07:02 PM
BAILEY DON MPresident and CEOSep 13Option Exercise5.1040,000204,000139,000Sep 17 05:33 PM
BAILEY DON MPresident and CEOSep 13Sale63.6940,0002,547,76699,000Sep 17 05:33 PM
Medeiros David JeffreyEVP and CTOAug 26Option Exercise5.1055,000280,500172,121Aug 27 08:02 PM
Medeiros David JeffreyEVP and CTOAug 26Sale73.9855,0004,068,984117,121Aug 27 08:02 PM
THOMPSON VIRGIL DDirectorAug 14Option Exercise5.775,00028,85034,867Aug 16 05:56 PM
THOMPSON VIRGIL DDirectorAug 14Sale69.125,000345,57729,867Aug 16 05:56 PM
Medeiros David JeffreyEVP and CTOAug 13Option Exercise2.45110,597270,815195,649Aug 15 06:16 PM
Medeiros David JeffreyEVP and CTOAug 13Sale67.85110,5977,503,745117,121Aug 15 06:16 PM
Medeiros David JeffreyEVP and CTOAug 06Option Exercise5.0248,831245,202165,052Aug 07 09:45 PM
Medeiros David JeffreyEVP and CTOAug 06Sale66.7348,8313,258,485117,121Aug 07 09:45 PM
Medeiros David JeffreyEVP and CTOAug 05Option Exercise1.3710,00013,700127,121Aug 07 09:45 PM
Medeiros David JeffreyEVP and CTOAug 05Sale66.5110,000665,134117,121Aug 07 09:45 PM
BAILEY DON MPresident and CEOJul 15Option Exercise5.0933,339169,696132,339Jul 17 06:37 PM
THOMPSON VIRGIL DDirectorJul 15Option Exercise5.775,00028,85034,867Jul 17 06:38 PM
THOMPSON VIRGIL DDirectorJul 15Sale49.295,000246,44929,867Jul 17 06:38 PM
BAILEY DON MPresident and CEOJul 15Sale49.3133,3391,644,10799,000Jul 17 06:37 PM
THOMPSON VIRGIL DDirectorJun 14Option Exercise4.755,00023,75034,867Jun 18 07:35 PM
Russell Angus C.DirectorJun 14Buy46.153,250149,9868,364Jun 18 07:31 PM
THOMPSON VIRGIL DDirectorJun 14Sale45.555,000227,73629,867Jun 18 07:35 PM
BAILEY DON MPresident and CEOJun 13Option Exercise5.0940,000203,600139,000Jun 14 08:10 PM
BAILEY DON MPresident and CEOJun 13Sale45.0140,0001,800,34099,000Jun 14 08:10 PM
BAILEY DON MPresident and CEOMay 14Option Exercise5.09160,000814,400259,000May 15 08:08 PM
THOMPSON VIRGIL DDirectorMay 14Option Exercise4.755,00023,75030,000May 16 02:15 PM
THOMPSON VIRGIL DDirectorMay 14Sale37.465,000187,30025,000May 16 02:15 PM
BAILEY DON MPresident and CEOMay 14Sale40.58160,0006,492,06299,000May 15 08:08 PM
BAILEY DON MPresident and CEOMay 13Option Exercise5.0920,000101,800119,000May 15 08:08 PM
BAILEY DON MPresident and CEOMay 13Sale36.7020,000734,00099,000May 15 08:08 PM
THOMPSON VIRGIL DDirectorMay 09Option Exercise4.752,18710,38827,187May 13 08:11 PM
THOMPSON VIRGIL DDirectorMay 09Sale35.002,18776,54525,000May 13 08:11 PM
BAILEY DON MPresident and CEOApr 25Option Exercise5.0910,03151,058109,031Apr 26 05:34 PM
BAILEY DON MPresident and CEOApr 25Sale30.0610,031301,57299,000Apr 26 05:34 PM
BAILEY DON MPresident and CEOApr 24Option Exercise5.099,96950,742108,969Apr 26 05:34 PM
BAILEY DON MPresident and CEOApr 24Sale30.009,969299,10299,000Apr 26 05:34 PM